Technology ID
TT-0106
Description
NCDriskClear AI™ creates a closed-loop platform from routine CBC/LFRT blood tests: it clears ≥99% NPV for stroke, heart attack, and cancer risks in three-highs patients, then generates personalized food supplement and medication guidance, with built-in monitoring for adaptive refinement. Unlike open-loop market alternatives (static quizzes or one-off recommendations), this continuously feeds new blood data back into models trained on 20+ years/7M+ HK public, validated 2020–2022, and prospectively testing in hospital clusters.
Content
True Closed-Loop Architecture: Blood input > risk clearance > supplement/med guidance > retest feedback loop, mirroring diabetes AID success
Lab-Verified Interventions: Guidance validated against actual blood outcomes, not surveys – superior to open-loop nutrition AI
Three-Highs Scale: Tailored for HK’s metabolic epidemic with region-specific supplement efficacy from 7M data
Prospective Hospital Proof: Live HA trials demonstrate loop effectiveness in real workflows
Regulatory Advantage: Combines SaMD clearance with adaptive DSS, positioning for rapid approvals
Inventors
Applicable Industries
Potential Application
Technology Focus
TRL